Microglial CD206 Gene Has Potential as a State Marker of Bipolar Disorder by Masahiro Ohgidani et al.
January 2017 | Volume 7 | Article 6761
PersPective
published: 09 January 2017
doi: 10.3389/fimmu.2016.00676
Frontiers in Immunology | www.frontiersin.org
Edited by: 
Björn Tackenberg, 
University of Marburg, Germany
Reviewed by: 
Björn Spittau, 
University of Freiburg, Germany 
Christiane Charriaut-Marlangue, 
INSERM, France
*Correspondence:
Takahiro A. Kato 
takahiro@npsych.med.kyushu-u.ac.jp
Specialty section: 
This article was submitted to Multiple 
Sclerosis and Neuroimmunology, 
a section of the journal 
Frontiers in Immunology
Received: 30 September 2016
Accepted: 21 December 2016
Published: 09 January 2017
Citation: 
Ohgidani M, Kato TA, Haraguchi Y, 
Matsushima T, Mizoguchi Y, 
Murakawa-Hirachi T, Sagata N, 
Monji A and Kanba S (2017) 
Microglial CD206 Gene Has Potential 
as a State Marker of Bipolar Disorder. 
Front. Immunol. 7:676. 
doi: 10.3389/fimmu.2016.00676
Microglial cD206 Gene Has Potential 
as a state Marker of Bipolar Disorder
Masahiro Ohgidani1, Takahiro A. Kato1,2*, Yoshinori Haraguchi3, Toshio Matsushima1, 
Yoshito Mizoguchi3, Toru Murakawa-Hirachi3, Noriaki Sagata1, Akira Monji3 and  
Shigenobu Kanba1
1 Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan, 2 Innovation 
Center for Medical Redox Navigation, Kyushu University, Fukuoka, Japan, 3 Department of Psychiatry, Graduate School of 
Medical Sciences, Saga University, Saga, Japan
The pathophysiology of bipolar disorder, especially the underlying mechanisms of the 
bipolarity between manic and depressive states, has yet to be clarified. Microglia, 
immune cells in the brain, play important roles in the process of brain inflammation, and 
recent positron emission tomography studies have indicated microglial overactivation 
in the brain of patients with bipolar disorder. We have recently developed a technique 
to induced microglia-like (iMG) cells from peripheral blood (monocytes). We introduce a 
novel translational approach focusing on bipolar disorder using this iMG technique. We 
hypothesize that immunological conditional changes in microglia may contribute to the 
shift between manic and depressive states, and thus we herein analyzed gene profiling 
patterns of iMG cells from three patients with rapid cycling bipolar disorder during both 
manic and depressive states, respectively. We revealed that the gene profiling patterns 
are different between manic and depressive states. The profiling pattern of case 1 
showed that M1 microglia is dominant in the manic state compared to the depressive 
state. However, the patterns of cases 2 and 3 were not consistent with the pattern of 
case 1. CD206, a mannose receptor known as a typical M2 marker, was significantly 
downregulated in the manic state among all three patients. This is the first report to indi-
cate the importance of shifting microglial M1/M2 characteristics, especially the CD206 
gene expression pattern between depressive and manic states. Further translational 
studies are needed to dig up the microglial roles in the underlying biological mechanisms 
of bipolar disorder.
Keywords: bipolar disorder, rapid cycling, microglia, cD206, induced microglia-like (iMG) cells, state marker, 
M1/M2 polarization, translational research
BiPOLAr DisOrDer AND MicrOGLiA
The pathophysiology of bipolar disorder has yet to be well understood, while recent studies have indi-
cated abnormal immunological functions may be a contributing factor (1, 2). Microglia, immune cells 
in the brain, play important roles in the process of brain inflammation, and recent positron emission 
tomography (PET) studies have shown microglial overactivation in the brain of patients with various 
psychiatric disorders including bipolar disorder (3–8). Based on the above evidence, microglia has 
FiGUre 1 | Analysis of iMG cells from a typical case with rapid cycling bipolar disorder. (A) Physical/mental activity of a patient with rapid cycling bipolar 
disorder for 3 months (case 1). (B) Gene profiling pattern of iMG cells from case 1 showed that M1 microglia is dominant in the manic state compared to the 
depressive state.
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been highlighted in the study of various psychiatric disorders to 
understand the underlying biological mechanisms (9–12).
We have recently developed a technique to induced 
microglia-like (iMG) cells from peripheral blood (13) and are 
now confirming the utilities of this technique for psychiatric 
research (14, 15). The underlying mechanisms of the bipolarity 
between manic and depressive states have yet to be clarified. 
Immunological conditional changes in microglia may contribute 
to the manic–depressive shift in bipolar disorder. In the field 
of immunology, M1/M2 polarization is recognized as a useful 
marker of macrophages and related cells including microglia. 
Polarization pattern is well known to distinguish functional 
phenotypes: pro-inflammation (M1) and anti-inflammation 
(M2) (16, 17). Recently, M1/M2 polarization has been high-
lighted in the understanding of psychiatric disorders (18–20). 
However, there is no research analyzing M1/M2 polarization of 
microglia in patients with bipolar disorder. We hypothesize that 
the expression profile of inflammation-related genes known as 
M1 (CD45, CD80, HLA-DR, TNF-α, IL-1β, and IL-23) or M2 
markers (CD206, CD209, CD23, BDNF, IL-10, and CCL18) of 
microglia may shift between manic and depressive states. In 
order to clarify this hypothesis, we herein analyzed iMG cells 
from three patients with rapid cycling bipolar disorder during 
both manic and depressive states, respectively.
FiGUre 2 | continued
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FiGUre 2 | Gene profiling pattern of iMG cells between depressive and manic states among three patients. (A) M1 markers, (B) M2 markers, and  
(c) statistical analysis of CD206 and CD45 among the three patients (mean value ± SD).
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M1/M2 MicrOGLiA AND BiPOLAr 
DisOrDer
Patients’ demographic data are shown in Table S1 in Supplementary 
Material. We produced iMG cells of each patient from both manic 
and depressive states and compared the gene expression profiles 
between both states. Relative gene expression (normalized by 
depressive state) of M1 and M2 markers are shown in Figures 1 
and 2A,B, respectively.
We revealed that the gene profiling patterns of iMG cells are 
different between manic and depressive states. The profiling pat-
tern of case 1 showed that M1 microglia is dominant in the manic 
state compared to the depressive state (Figure 1B). However, the 
patterns of cases 2 and 3 were not consistent with the pattern of 
case 1 (Figures 2A,B).
For M1 markers, CD45 was downregulated in the manic state 
among all three patients. Other M1 markers such as TNF-α, IL-1β, 
IL-23, CD80, and HLA-DR shifted differently among the patients 
(Figure 2A). For M2 markers, CD206 was downregulated in the 
manic state among all three patients. Other M2 markers such 
as BDNF, IL-10, CCL18, CD23, and CD209 shifted differently 
among the patients (Figure 2B). Thus, we performed statistical 
analysis [Student’s t-test (two-tailed)] among the three patients. 
As shown in Figure 2C, CD206 was significantly downregulated 
in the manic state (p = 0.012). On the other hand, CD45 showed 
no significant difference between manic and depressive states 
(p = 0.057).
cD206 AND MicrOGLiA
In the present study, we have shown that downregulation of the 
CD206 gene of iMG cells in the manic state was consistent across all 
three patients with bipolar disorder. CD206, known as a mannose 
receptor, is a 175-kDa transmembrane protein, mostly expressed 
by macrophages, dendritic cells, and endothelial cells. This recep-
tor selectively and efficiently captures mannosylated ligands such 
as microbial antigen (21). In the brain, CD206 is also expressed 
in microglia (22, 23) and astrocytes (24, 25). CD206 is widely 
recognized as a typical M2 microglial marker (23, 26, 27). CD206 
has some important cellular functions especially in pinocytosis 
and phagocytosis on microglia (22, 25, 28–30). Therefore, CD206 
may be critical as the first step in the recognition and capture of 
pathogens in the brain (25). To date, there are no studies focusing 
on microglial CD206 in psychiatric disorders including bipolar 
disorder. In the present study, CD206 was downregulated in the 
manic state. This finding might suggest that the manic state of 
microglia is more vulnerable to the pathogen and/or insoluble 
matter compared to the depressive state. Based on the present 
results, M2 microglia may be dominant in the depressive state in 
patients with bipolar disorder, especially rapid cycling patients. 
Further translational investigations should be conducted to 
clarify our hypothesis.
LiMitAtiON AND FUtUre PersPectives
One major limitation of the present study is that all three patients 
were on medication. Given that it took 2 weeks to induce iMG 
cells, the influence of medication is assumed to be minimal. 
Additional studies are needed in medication-free patients. On 
the other hand, recent PET studies have suggested microglial 
overactivation in patients with bipolar disorder (7, 8). Thus, 
human PET studies should be conducted in patients with bipolar 
disorder during both manic–depressive states. However, even the 
most advanced brain imaging techniques cannot analyze M1/M2 
polarization in the human brain, and thus we believe that the iMG 
technique has an advantage for such analyses in translational 
research.
A recent study has revealed that the origin of brain microglia is 
primitive macrophages migrated from the yolk sac before embry-
onic day 8 (31). One of the limitations in the present study is that 
iMG cells are not actual microglial cells in the brain. However, we 
believe that our iMG cells are surrogate cells, which can represent 
some of the characteristics of brain microglial cells (13). Further 
comparison studies are needed to investigate the similarity and 
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differences between brain microglial cells and iMG cells in more 
detail.
The life span of intravascular blood monocytes is only a 
few days long (32). Thus, we believe that the iMG cells from 
peripheral blood monocytes are useful not only as a trait marker 
but also as a state marker in order to assess a variety of mental 
states. However, an inherent limitation of our iMG analysis is the 
time delay between the date of blood collection and the date of 
analysis of iMG cells (after 14 days) due to the necessity of 14-day 
induction from blood monocytes. Further investigations should 
be conducted to clarify the impact of time delays in analysis of 
iMG cells.
The underlying biological mechanism shifting the expression 
patterns of iMG cells between depressive and manic states has 
not been clarified at present, while some internal and/or external 
factors are suggested to contribute to this shifting mechanism. 
Recent immunological studies have suggested that immune cell 
activities, including microglia, are modulated by the circadian 
clock system (33), methylation (34), and/or external stress (35), 
which may contribute to the activation patterns of microglia dur-
ing clinical courses of bipolar disorder.
A previous study has shown that peripheral blood mono-
nuclear cells from patients with rapid cycling bipolar disorder 
presented a different pattern of gene expression between manic 
and depressive states (36). In addition to the present study, this 
report also supports the premise that the cellular phenotype of 
microglia including M1/M2 state is different between depressive 
and manic states. Further studies are required to determine the 
clinical importance of these pilot findings.
cONcLUsiON
We introduced a novel translational approach focusing on 
bipolar disorder using the iMG technique. To our knowledge, 
this is the first report to indicate the importance of shifting 
microglial CD206 gene expression between depressive and 
manic states. This study is the first step toward understanding 
the contribution of microglia to the pathogenesis of bipolar 
disorders. Further studies are needed to dig up the microglial 
roles in bipolar disorder.
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